The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.
Inspection Record
Accord Healthcare Inc. — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
Evaluation of production processes, equipment, and/or materials was inadequate.
The annual product quality review procedure was inadequate.
The quality agreement outlining the responsibilities for fabricating, packaging or labelling, and/or testing was inadequate.
The training of personnel in good manufacturing practices and/or the maintenance of records was inadequate.
The written agreement for outsourcing fabrication, packaging or labelling, and/or testing activities was inadequate.
The importer did not ensure that the foreign sites use to fabricate, package/label, or test drug products met the requirements described in Guidance on Evidence to Demonstrate Drug GMP Compliance of Foreign Sites (GUI-0080).
The evidence required to demonstrate compliance with finished product specifications was inadequate.
About this record
Extracted automatically from the document of the Health Canada inspection on 2022-02-02. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
